antivdac1 Search Results


94
Agrisera anti vdac
a, Analysis of the interaction of His-GSNOR1 and GST-VDAC recombinant proteins by a GST pull-down assay. GST protein was used as a negative control. b, Analysis of the interaction between GSNOR1 and VDAC proteins by co-immunoprecipitation (Co-IP) in 8-day-old wild-type (WT) and GSNOR1-FLAG transgenic seedlings (left), and in GSNOR1-FLAG transgenic seedlings treated with or without 50 µM DNP for 2 h (right). Quantification is shown below the blot. The relative protein level in samples without DNP treatment was set as 1.0. The <t>polyclonal</t> <t>anti-VDAC</t> antibody recognizes VDAC1 through VDAC4 proteins. c, Analysis of the interaction of GSNOR1 and VDAC proteins by a luciferase complementation imaging assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. The assay was performed 2 days post-infiltration. d, Analysis of the interaction of GSNOR1 and VDAC proteins by a bimolecular fluorescence complementation assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. Confocal microscopy was performed 2 days post-infiltration. Co-localization signals are shown in boxed regions. Scale bar, 20 µm. e, Confocal microscopy of Arabidopsis protoplast cells transformed with GSNOR1-GFP and FLAG-mCherry-VDAC3 transgenes. Co-localization signals are shown in enlarged views of the boxed regions. Scale bar, 10 µm.
Anti Vdac, supplied by Agrisera, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/Anti-VDAC1-5/bio_rxiv__64898__2026__10__28__758855-251-52-53
Average 94 stars, based on 1 article reviews
anti vdac - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
NeuroMab vdac
A) Immunoblot of pan-acetylation, normalized to <t>VDAC,</t> for liver mitochondrial enrichment from 25-month-old treatment groups. Data were analyzed by two-way ANOVA followed by multiple comparisons test. p value reported for each comparison is corrected by Tukey’s test. Results are plotted as mean ± SEM. *: p≤0.05. B) Percentage of significantly changed acetyl-lysine residues that show increased stoichiometry due <t>to</t> <t>Sirt3</t> -/- , calculated by (the number of acetyl-lysine sites showing increased stoichiometry) / (the number of significantly changed acetyl-lysine sites, p<0.05) x100%. C) Heat map of significantly changed lysine sites (p<0.1) that are response to loss of SIRT3. Plotted sites are significantly changed (p<0.1) in either Sirt3 -/- CD vs. WTCD or Sirt3 -/- CR vs. WTCR comparison. Values are colored based on relative acetylation stoichiometry, normalized to the median value of each sites in all four groups, scaling ranging from -0.8 to 0.8 (x100%). D) Functional cluster analysis of KEGG pathways (DAVID 6.8). Significantly enriched (-log10(p value) >1.5) pathways are indicated, with Sirt3 -/- CD vs. WTCD in orange and Sirt3 -/- CR vs. WTCR in blue. E) Acetylation sites in FAO and BACC metabolism, TCA cycle, and ETC that displayed larger than 5% stoichiometry (p<0.1) for Sirt3 -/- CD vs. WTCD (orange colored) and Sirt3 -/- CR vs. WTCR comparison (blue colored).
Vdac, supplied by NeuroMab, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/Anti-VDAC1+Antibody/bio_rxiv__2022__05__09__491205-318-14-16
Average 94 stars, based on 1 article reviews
vdac - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Atlas Antibodies abcam against vdac1
a MOLM14 cells treated with metformin (Met, 10 mM) for 24 h were fixed and processed for electron microscopy analysis. Representative electron microscopy pictures from two independent experiments are shown. Arrows indicate MERCs. Scale bar: 1 µm. b Histograms represent the % of mitochondria that are in contact with endoplasmic reticulum per cell treated or not with Met from pictures displayed in a . Data are means ± s.e.m with each dot corresponding to one cell. c Protein components of subcellular fractions (left panel) from two independent experiments prepared from MOLM14 cells revealed by immunoblot analysis (right panel). TL: total lysate, Cy: cytosol, Mt: pure mitochondrial fraction, MERCs: mitochondria–ER contact site fraction. d Representative orthogonal confocal projections of Z sections of PLA (red signal) between <t>VDAC1</t> and IP3R1 from MOLM14 cells treated or not with Met or antimycin A (AA) for 48 h (at least n = 3). Scale bar: 10 µm e Quantitative analysis of PLA signal between VDAC1 and IP3R1 from MOLM14 cells treated or not with Met or AA for 6 h, 24 h or 48 h ( n = 4, one-sample t -test). Data are means ± s.e.m.
Abcam Against Vdac1, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/Anti-VDAC1/pmc07426880-232-19-35
Average 90 stars, based on 1 article reviews
abcam against vdac1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sangon Biotech anti-vdac1
a MOLM14 cells treated with metformin (Met, 10 mM) for 24 h were fixed and processed for electron microscopy analysis. Representative electron microscopy pictures from two independent experiments are shown. Arrows indicate MERCs. Scale bar: 1 µm. b Histograms represent the % of mitochondria that are in contact with endoplasmic reticulum per cell treated or not with Met from pictures displayed in a . Data are means ± s.e.m with each dot corresponding to one cell. c Protein components of subcellular fractions (left panel) from two independent experiments prepared from MOLM14 cells revealed by immunoblot analysis (right panel). TL: total lysate, Cy: cytosol, Mt: pure mitochondrial fraction, MERCs: mitochondria–ER contact site fraction. d Representative orthogonal confocal projections of Z sections of PLA (red signal) between <t>VDAC1</t> and IP3R1 from MOLM14 cells treated or not with Met or antimycin A (AA) for 48 h (at least n = 3). Scale bar: 10 µm e Quantitative analysis of PLA signal between VDAC1 and IP3R1 from MOLM14 cells treated or not with Met or AA for 6 h, 24 h or 48 h ( n = 4, one-sample t -test). Data are means ± s.e.m.
Anti Vdac1, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/anti+vdac1/pm39680522-70-31-32
Average 90 stars, based on 1 article reviews
anti-vdac1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co anti-vdac1
Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 <t>(VDAC1),</t> and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.
Anti Vdac1, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/anti+vdac/pmc07305196-234-104-105
Average 90 stars, based on 1 article reviews
anti-vdac1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenScript corporation vdac1 genescript a01914
Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 <t>(VDAC1),</t> and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.
Vdac1 Genescript A01914, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/anti+vdac1/pmc10645387__jci___133___169399___s015-191-69-71
Average 90 stars, based on 1 article reviews
vdac1 genescript a01914 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Wanleibio anti-vdac1
Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 <t>(VDAC1),</t> and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.
Anti Vdac1, supplied by Wanleibio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/antivdac1+wl02790/pmc10591013-102-19-21
Average 90 stars, based on 1 article reviews
anti-vdac1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Abnova rabbit polyclonal anti-vdac1 antibody
Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 <t>(VDAC1),</t> and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.
Rabbit Polyclonal Anti Vdac1 Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/rabbit+polyclonal+anti+vdac1+antibody/pm23313576-42-9-14
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-vdac1 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bioscientifica Ltd vdac1 protein
Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 <t>(VDAC1),</t> and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.
Vdac1 Protein, supplied by Bioscientifica Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/anti+vdac1/pm23722227-217-0-13
Average 90 stars, based on 1 article reviews
vdac1 protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co mouse anti-vdac1 (porin
Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 <t>(VDAC1),</t> and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.
Mouse Anti Vdac1 (Porin, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/vdac1/pmc05445257-73-17-21
Average 90 stars, based on 1 article reviews
mouse anti-vdac1 (porin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co anti-vdac1/porin
( A ) SDS-PAGE and Western blot analysis of cytosolic and mitochondrial fractions isolated from PHSFs from control subjects (CT1, CT2) and the three patients (P1-EMRE, P2-EMRE, P3-MICU1). Antibodies against EMRE, MICU1, MCU, <t>VDAC1</t> (mitochondrial marker) and β-actin (cytosolic marker) were used. Two EMRE-positive bands were detected in CT1 and CT2 cells (green boxes), whereas such bands were not detected in P1-EMRE, P2-EMRE and P3-MICU1 cells (red boxes). The saturated (red) pixels on the left of the blot are derived from the MW markers (also see Supplementary figure 2 ). Numerals indicate molecular weight in kDa. ( B ) Native gel (BN-PAGE) and Western blot analysis of mitochondria-enriched fractions isolated from PHSFs and stained with antibodies against MCU and OXPHOS complex II (CII; loading control). The fully assembled MCU complex (“MCU complex”) and the subcomplex lacking the EMRE or MICU1 subunit (“MCU subcomplex”) are indicated.
Anti Vdac1/Porin, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/anti/bio_rxiv__2022__10__31__514480-261-53-56
Average 90 stars, based on 1 article reviews
anti-vdac1/porin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Enzo Biochem anti-vdac
( A ) SDS-PAGE and Western blot analysis of cytosolic and mitochondrial fractions isolated from PHSFs from control subjects (CT1, CT2) and the three patients (P1-EMRE, P2-EMRE, P3-MICU1). Antibodies against EMRE, MICU1, MCU, <t>VDAC1</t> (mitochondrial marker) and β-actin (cytosolic marker) were used. Two EMRE-positive bands were detected in CT1 and CT2 cells (green boxes), whereas such bands were not detected in P1-EMRE, P2-EMRE and P3-MICU1 cells (red boxes). The saturated (red) pixels on the left of the blot are derived from the MW markers (also see Supplementary figure 2 ). Numerals indicate molecular weight in kDa. ( B ) Native gel (BN-PAGE) and Western blot analysis of mitochondria-enriched fractions isolated from PHSFs and stained with antibodies against MCU and OXPHOS complex II (CII; loading control). The fully assembled MCU complex (“MCU complex”) and the subcomplex lacking the EMRE or MICU1 subunit (“MCU subcomplex”) are indicated.
Anti Vdac, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antivdac1/anti+vdac1+3/pmc01817793-79-63-67
Average 90 stars, based on 1 article reviews
anti-vdac - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


a, Analysis of the interaction of His-GSNOR1 and GST-VDAC recombinant proteins by a GST pull-down assay. GST protein was used as a negative control. b, Analysis of the interaction between GSNOR1 and VDAC proteins by co-immunoprecipitation (Co-IP) in 8-day-old wild-type (WT) and GSNOR1-FLAG transgenic seedlings (left), and in GSNOR1-FLAG transgenic seedlings treated with or without 50 µM DNP for 2 h (right). Quantification is shown below the blot. The relative protein level in samples without DNP treatment was set as 1.0. The polyclonal anti-VDAC antibody recognizes VDAC1 through VDAC4 proteins. c, Analysis of the interaction of GSNOR1 and VDAC proteins by a luciferase complementation imaging assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. The assay was performed 2 days post-infiltration. d, Analysis of the interaction of GSNOR1 and VDAC proteins by a bimolecular fluorescence complementation assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. Confocal microscopy was performed 2 days post-infiltration. Co-localization signals are shown in boxed regions. Scale bar, 20 µm. e, Confocal microscopy of Arabidopsis protoplast cells transformed with GSNOR1-GFP and FLAG-mCherry-VDAC3 transgenes. Co-localization signals are shown in enlarged views of the boxed regions. Scale bar, 10 µm.

Journal: bioRxiv

Article Title: S -nitrosoglutathione reductase acts as a mitophagy receptor to control mitochondrial quality in plants

doi: 10.64898/2026.10.28.758855

Figure Lengend Snippet: a, Analysis of the interaction of His-GSNOR1 and GST-VDAC recombinant proteins by a GST pull-down assay. GST protein was used as a negative control. b, Analysis of the interaction between GSNOR1 and VDAC proteins by co-immunoprecipitation (Co-IP) in 8-day-old wild-type (WT) and GSNOR1-FLAG transgenic seedlings (left), and in GSNOR1-FLAG transgenic seedlings treated with or without 50 µM DNP for 2 h (right). Quantification is shown below the blot. The relative protein level in samples without DNP treatment was set as 1.0. The polyclonal anti-VDAC antibody recognizes VDAC1 through VDAC4 proteins. c, Analysis of the interaction of GSNOR1 and VDAC proteins by a luciferase complementation imaging assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. The assay was performed 2 days post-infiltration. d, Analysis of the interaction of GSNOR1 and VDAC proteins by a bimolecular fluorescence complementation assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. Confocal microscopy was performed 2 days post-infiltration. Co-localization signals are shown in boxed regions. Scale bar, 20 µm. e, Confocal microscopy of Arabidopsis protoplast cells transformed with GSNOR1-GFP and FLAG-mCherry-VDAC3 transgenes. Co-localization signals are shown in enlarged views of the boxed regions. Scale bar, 10 µm.

Article Snippet: The following antibodies were obtained from commercial sources: anti-ATG8 (Agrisera, Cat # AS142811), anti-COXII (Agrisera, Cat # AS04053A), anti-GFP (Invitrogen, Cat # MA5-15256), anti-GST (CoWin Biotech, Cat # CW0084), anti-His (Engibody, Cat # AT0025), anti-HSP70 (Agrisera, Cat # AS08347), anti-HSP82 (Beijing Protein Innovation, Cat # AbM51099-31-PU), anti-MBP (EMAR, Cat # EM33019), and anti-VDAC (Agrisera, Cat # AS07212).

Techniques: Analysis, Recombinant, GST Pulldown Assay, Negative Control, Co-Immunoprecipitation Assay, Transgenic Assay, Luciferase, Imaging, Transformation Assay, Bimolecular Fluorescence Complementation Assay, Confocal, Microscopy

a, Analysis of the interaction of GST-VDAC and His-ATG8a recombinant proteins by a GST pull-down assay. GST protein was used as a negative control. b, Analysis of the interaction of VDAC and ATG8a proteins by a co-immunoprecipitation (Co-IP) assay in 8-day-old seedlings carrying GFP or GFP-ATG8a transgenes. The polyclonal anti-VDAC antibody recognizes VDAC1 through VDAC4 proteins. c, Analysis of the interaction of VDAC3 and ATG8a proteins by a bimolecular fluorescence complementation assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. Confocal microscopy was performed 2 days post-infiltration. Co-localization signals are shown in the boxed regions. Scale bar, 20 µm. d, Confocal microscopy of Arabidopsis protoplasts transformed with FLAG-mCherry-VDAC3 and eGFP-ATG8a transgenes. White arrowheads indicate punctate co-localization signals. Scale bar, 10 µm. e, Schematic representations of wild-type (WT) VDAC3 and deletion mutants fused to GST (GST not shown in the diagrams). f, Confocal microscopy of Arabidopsis protoplasts transiently expressing eGFP-VDAC3, eGFP-D1, or eGFP-D2. Protoplasts were stained with 200 nM MitoTracker Red for 15 min prior to imaging. Scale bars, 10 µm. g,h, Analysis of the interaction of wild-type (WT) GST-VDAC3 with D1 through D5 mutant recombinant proteins shown in ( e ) with His-ATG8a ( g ) or His-GSNOR1 ( h ) recombinant proteins by a GST pull-down assay. i, A projected 3-D structure of Arabidopsis VDAC3 protein trained with human hVDAC1 (PDB code: 2K4T) as a model. N1, N2, and N3 denote the putative α-helixes (N1 and N2) and a putative β-sheet (N3), of which are covered by deletional mutations D6-D8 shown in ( e ), respectively. j,k, Analysis of the interaction of wild-type (WT) GST-VDAC3 and D6-D8 mutant recombinant proteins shown in ( e ) with His-ATG8a ( j ) or His-GSNOR1 ( k ) recombinant proteins by a GST pull-down assay.

Journal: bioRxiv

Article Title: S -nitrosoglutathione reductase acts as a mitophagy receptor to control mitochondrial quality in plants

doi: 10.64898/2026.10.28.758855

Figure Lengend Snippet: a, Analysis of the interaction of GST-VDAC and His-ATG8a recombinant proteins by a GST pull-down assay. GST protein was used as a negative control. b, Analysis of the interaction of VDAC and ATG8a proteins by a co-immunoprecipitation (Co-IP) assay in 8-day-old seedlings carrying GFP or GFP-ATG8a transgenes. The polyclonal anti-VDAC antibody recognizes VDAC1 through VDAC4 proteins. c, Analysis of the interaction of VDAC3 and ATG8a proteins by a bimolecular fluorescence complementation assay in tobacco leaves infiltrated with Agrobacterium transformed with various combinations of transgenes as indicated. Confocal microscopy was performed 2 days post-infiltration. Co-localization signals are shown in the boxed regions. Scale bar, 20 µm. d, Confocal microscopy of Arabidopsis protoplasts transformed with FLAG-mCherry-VDAC3 and eGFP-ATG8a transgenes. White arrowheads indicate punctate co-localization signals. Scale bar, 10 µm. e, Schematic representations of wild-type (WT) VDAC3 and deletion mutants fused to GST (GST not shown in the diagrams). f, Confocal microscopy of Arabidopsis protoplasts transiently expressing eGFP-VDAC3, eGFP-D1, or eGFP-D2. Protoplasts were stained with 200 nM MitoTracker Red for 15 min prior to imaging. Scale bars, 10 µm. g,h, Analysis of the interaction of wild-type (WT) GST-VDAC3 with D1 through D5 mutant recombinant proteins shown in ( e ) with His-ATG8a ( g ) or His-GSNOR1 ( h ) recombinant proteins by a GST pull-down assay. i, A projected 3-D structure of Arabidopsis VDAC3 protein trained with human hVDAC1 (PDB code: 2K4T) as a model. N1, N2, and N3 denote the putative α-helixes (N1 and N2) and a putative β-sheet (N3), of which are covered by deletional mutations D6-D8 shown in ( e ), respectively. j,k, Analysis of the interaction of wild-type (WT) GST-VDAC3 and D6-D8 mutant recombinant proteins shown in ( e ) with His-ATG8a ( j ) or His-GSNOR1 ( k ) recombinant proteins by a GST pull-down assay.

Article Snippet: The following antibodies were obtained from commercial sources: anti-ATG8 (Agrisera, Cat # AS142811), anti-COXII (Agrisera, Cat # AS04053A), anti-GFP (Invitrogen, Cat # MA5-15256), anti-GST (CoWin Biotech, Cat # CW0084), anti-His (Engibody, Cat # AT0025), anti-HSP70 (Agrisera, Cat # AS08347), anti-HSP82 (Beijing Protein Innovation, Cat # AbM51099-31-PU), anti-MBP (EMAR, Cat # EM33019), and anti-VDAC (Agrisera, Cat # AS07212).

Techniques: Analysis, Recombinant, GST Pulldown Assay, Negative Control, Co-Immunoprecipitation Assay, Bimolecular Fluorescence Complementation Assay, Transformation Assay, Confocal, Microscopy, Expressing, Staining, Imaging, Mutagenesis

A) Immunoblot of pan-acetylation, normalized to VDAC, for liver mitochondrial enrichment from 25-month-old treatment groups. Data were analyzed by two-way ANOVA followed by multiple comparisons test. p value reported for each comparison is corrected by Tukey’s test. Results are plotted as mean ± SEM. *: p≤0.05. B) Percentage of significantly changed acetyl-lysine residues that show increased stoichiometry due to Sirt3 -/- , calculated by (the number of acetyl-lysine sites showing increased stoichiometry) / (the number of significantly changed acetyl-lysine sites, p<0.05) x100%. C) Heat map of significantly changed lysine sites (p<0.1) that are response to loss of SIRT3. Plotted sites are significantly changed (p<0.1) in either Sirt3 -/- CD vs. WTCD or Sirt3 -/- CR vs. WTCR comparison. Values are colored based on relative acetylation stoichiometry, normalized to the median value of each sites in all four groups, scaling ranging from -0.8 to 0.8 (x100%). D) Functional cluster analysis of KEGG pathways (DAVID 6.8). Significantly enriched (-log10(p value) >1.5) pathways are indicated, with Sirt3 -/- CD vs. WTCD in orange and Sirt3 -/- CR vs. WTCR in blue. E) Acetylation sites in FAO and BACC metabolism, TCA cycle, and ETC that displayed larger than 5% stoichiometry (p<0.1) for Sirt3 -/- CD vs. WTCD (orange colored) and Sirt3 -/- CR vs. WTCR comparison (blue colored).

Journal: bioRxiv

Article Title: SIRT3 deficiency decreases oxidative-metabolism capacity but increases lifespan under caloric restriction

doi: 10.1101/2022.05.09.491205

Figure Lengend Snippet: A) Immunoblot of pan-acetylation, normalized to VDAC, for liver mitochondrial enrichment from 25-month-old treatment groups. Data were analyzed by two-way ANOVA followed by multiple comparisons test. p value reported for each comparison is corrected by Tukey’s test. Results are plotted as mean ± SEM. *: p≤0.05. B) Percentage of significantly changed acetyl-lysine residues that show increased stoichiometry due to Sirt3 -/- , calculated by (the number of acetyl-lysine sites showing increased stoichiometry) / (the number of significantly changed acetyl-lysine sites, p<0.05) x100%. C) Heat map of significantly changed lysine sites (p<0.1) that are response to loss of SIRT3. Plotted sites are significantly changed (p<0.1) in either Sirt3 -/- CD vs. WTCD or Sirt3 -/- CR vs. WTCR comparison. Values are colored based on relative acetylation stoichiometry, normalized to the median value of each sites in all four groups, scaling ranging from -0.8 to 0.8 (x100%). D) Functional cluster analysis of KEGG pathways (DAVID 6.8). Significantly enriched (-log10(p value) >1.5) pathways are indicated, with Sirt3 -/- CD vs. WTCD in orange and Sirt3 -/- CR vs. WTCR in blue. E) Acetylation sites in FAO and BACC metabolism, TCA cycle, and ETC that displayed larger than 5% stoichiometry (p<0.1) for Sirt3 -/- CD vs. WTCD (orange colored) and Sirt3 -/- CR vs. WTCR comparison (blue colored).

Article Snippet: Western blot primary antibodies used include: SIRT3 (#5490, CST, 1:1000), Acetylated-Lysine (#9681, CST, 1:1000), VDAC (75-204, NeuroMab, 1:1250).

Techniques: Western Blot, Comparison, Functional Assay

a MOLM14 cells treated with metformin (Met, 10 mM) for 24 h were fixed and processed for electron microscopy analysis. Representative electron microscopy pictures from two independent experiments are shown. Arrows indicate MERCs. Scale bar: 1 µm. b Histograms represent the % of mitochondria that are in contact with endoplasmic reticulum per cell treated or not with Met from pictures displayed in a . Data are means ± s.e.m with each dot corresponding to one cell. c Protein components of subcellular fractions (left panel) from two independent experiments prepared from MOLM14 cells revealed by immunoblot analysis (right panel). TL: total lysate, Cy: cytosol, Mt: pure mitochondrial fraction, MERCs: mitochondria–ER contact site fraction. d Representative orthogonal confocal projections of Z sections of PLA (red signal) between VDAC1 and IP3R1 from MOLM14 cells treated or not with Met or antimycin A (AA) for 48 h (at least n = 3). Scale bar: 10 µm e Quantitative analysis of PLA signal between VDAC1 and IP3R1 from MOLM14 cells treated or not with Met or AA for 6 h, 24 h or 48 h ( n = 4, one-sample t -test). Data are means ± s.e.m.

Journal: Nature Communications

Article Title: Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites

doi: 10.1038/s41467-020-17882-2

Figure Lengend Snippet: a MOLM14 cells treated with metformin (Met, 10 mM) for 24 h were fixed and processed for electron microscopy analysis. Representative electron microscopy pictures from two independent experiments are shown. Arrows indicate MERCs. Scale bar: 1 µm. b Histograms represent the % of mitochondria that are in contact with endoplasmic reticulum per cell treated or not with Met from pictures displayed in a . Data are means ± s.e.m with each dot corresponding to one cell. c Protein components of subcellular fractions (left panel) from two independent experiments prepared from MOLM14 cells revealed by immunoblot analysis (right panel). TL: total lysate, Cy: cytosol, Mt: pure mitochondrial fraction, MERCs: mitochondria–ER contact site fraction. d Representative orthogonal confocal projections of Z sections of PLA (red signal) between VDAC1 and IP3R1 from MOLM14 cells treated or not with Met or antimycin A (AA) for 48 h (at least n = 3). Scale bar: 10 µm e Quantitative analysis of PLA signal between VDAC1 and IP3R1 from MOLM14 cells treated or not with Met or AA for 6 h, 24 h or 48 h ( n = 4, one-sample t -test). Data are means ± s.e.m.

Article Snippet: Mouse antibodies from Santa Cruz Biotechnology against IP3R1 (sc-271197) and E2F1 (KH95), from Millipore against actin, rabbit antibody from Abcam against VDAC1 (ab15865), from PROGEN against ADRP (610102), from R&D System against FABP4 (AF3150), from Atlas Antibodies against ACLY (HPA022434), from Novus Biologicals against SREPB1 (NB600-582), from Invitrogen against SREBP2 (PA1-338), and from GeneTex against TOMM20 (GTX133756) were also used.

Techniques: Electron Microscopy, Western Blot

a MOLM14 cells transfected with siRNA control (Ctrl) or mitofusin2 (Mtfn2) were processed for electron microscopy analysis. Electron microscopy pictures from one experiment are shown. Scale bar: 1 µm. b Histograms represent the % of mitochondria in contact with ER. Each dot corresponding to one cell. c Images of proximity ligation assay between VDAC1 and IP3R1 from MOLM14 transfected with Ctrl or Mtfn2 siRNAs ( n = 3). Scale bar: 10 µm. Numbers represent the % of dots in cells transfected with siRNA Mtfn2 compared with cells transfected with siRNA Ctrl. d , e MOLM14 cells were transduced with Ctrl or VDAC1 shRNAs ( n = 4) or transfected with Ctrl or Mtfn2 siRNAs ( n = 6), and stained for LC3B and DAPI. Confocal sections (at least four independent experiments) are shown. Scale bar: 10 µm ( d ). Histograms represent the number of LC3B puncta per cell ( e ) (unpaired t -test). f , g MOLM14 cells transduced with Ctrl or VDAC1 shRNAs ( n = 3) or transfected with Ctrl or Mtfn2 siRNAs ( n = 6) were stained for Bodipy and DAPI. Scale bar: 10 µm, ( f ). Histograms show the number or the area of Bodipy dots per cell ( g ) (unpaired t -test). h Measurement of basal oxygen consumption rate (OCR) in MOLM14 cells transduced with Ctrl or VDAC1 shRNAs ( n = 6) or transfected with Ctrl or Mtfn2 siRNAs ( n = 6, unpaired t -test). i , j MOLM14 cells transfected with Ctrl or Beclin1 (Bec) or Mtfn2 siRNAs and incubated with RC 12 , were stained for TOMM20 and confocal Z- stacks were acquired (three independent experiments). Scale bar: 10 µm ( i ). Fraction of RC 12 overlapping TOMM20 staining ( j ). siCtrl ( n = 17), siBec ( n = 18), and siMtfn2 ( n = 13, unpaired t -test). k Measurement of OCR in MOLM14 cells transfected with Ctrl ( n = 8), Bec ( n = 7), or Mtfn2 siRNAs ( n = 8) ± Oleate-BSA. l – o MOLM14 cells were transduced with the mitochondria–ER organelle linker (OMM-ER) and its control (OMM), treated ± metformin, and subjected to Western blot analysis for actin and LC3B ( l , m ) or stained for Bodipy and DAPI ( n , o ) (three independent experiments). Scale bar: 10 µm. Histograms represent the number of LC3B puncta ( m ) or the area of Bodipy dots per cell ( o ) unpaired t -test. Data are means ± s.e.m.

Journal: Nature Communications

Article Title: Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites

doi: 10.1038/s41467-020-17882-2

Figure Lengend Snippet: a MOLM14 cells transfected with siRNA control (Ctrl) or mitofusin2 (Mtfn2) were processed for electron microscopy analysis. Electron microscopy pictures from one experiment are shown. Scale bar: 1 µm. b Histograms represent the % of mitochondria in contact with ER. Each dot corresponding to one cell. c Images of proximity ligation assay between VDAC1 and IP3R1 from MOLM14 transfected with Ctrl or Mtfn2 siRNAs ( n = 3). Scale bar: 10 µm. Numbers represent the % of dots in cells transfected with siRNA Mtfn2 compared with cells transfected with siRNA Ctrl. d , e MOLM14 cells were transduced with Ctrl or VDAC1 shRNAs ( n = 4) or transfected with Ctrl or Mtfn2 siRNAs ( n = 6), and stained for LC3B and DAPI. Confocal sections (at least four independent experiments) are shown. Scale bar: 10 µm ( d ). Histograms represent the number of LC3B puncta per cell ( e ) (unpaired t -test). f , g MOLM14 cells transduced with Ctrl or VDAC1 shRNAs ( n = 3) or transfected with Ctrl or Mtfn2 siRNAs ( n = 6) were stained for Bodipy and DAPI. Scale bar: 10 µm, ( f ). Histograms show the number or the area of Bodipy dots per cell ( g ) (unpaired t -test). h Measurement of basal oxygen consumption rate (OCR) in MOLM14 cells transduced with Ctrl or VDAC1 shRNAs ( n = 6) or transfected with Ctrl or Mtfn2 siRNAs ( n = 6, unpaired t -test). i , j MOLM14 cells transfected with Ctrl or Beclin1 (Bec) or Mtfn2 siRNAs and incubated with RC 12 , were stained for TOMM20 and confocal Z- stacks were acquired (three independent experiments). Scale bar: 10 µm ( i ). Fraction of RC 12 overlapping TOMM20 staining ( j ). siCtrl ( n = 17), siBec ( n = 18), and siMtfn2 ( n = 13, unpaired t -test). k Measurement of OCR in MOLM14 cells transfected with Ctrl ( n = 8), Bec ( n = 7), or Mtfn2 siRNAs ( n = 8) ± Oleate-BSA. l – o MOLM14 cells were transduced with the mitochondria–ER organelle linker (OMM-ER) and its control (OMM), treated ± metformin, and subjected to Western blot analysis for actin and LC3B ( l , m ) or stained for Bodipy and DAPI ( n , o ) (three independent experiments). Scale bar: 10 µm. Histograms represent the number of LC3B puncta ( m ) or the area of Bodipy dots per cell ( o ) unpaired t -test. Data are means ± s.e.m.

Article Snippet: Mouse antibodies from Santa Cruz Biotechnology against IP3R1 (sc-271197) and E2F1 (KH95), from Millipore against actin, rabbit antibody from Abcam against VDAC1 (ab15865), from PROGEN against ADRP (610102), from R&D System against FABP4 (AF3150), from Atlas Antibodies against ACLY (HPA022434), from Novus Biologicals against SREPB1 (NB600-582), from Invitrogen against SREBP2 (PA1-338), and from GeneTex against TOMM20 (GTX133756) were also used.

Techniques: Transfection, Control, Electron Microscopy, Proximity Ligation Assay, Transduction, Staining, Incubation, Western Blot

a , b NSG mice ( n = 31) were engrafted with MOLM14 cells expressing the Ctrl or VDAC1 shRNAs by intravenous injection. Seventeen days post graft, five mice shCtrl and six mice shVDAC1 were killed, and the number of human cells (hCD45+ and hCD33+) in the bone marrow and spleen was analyzed by flow cytometry. Graphs represent the number of human positive cells for hCD45 and hCD33 within the murine bone marrow and spleen from one experiment ( a ) (unpaired t -test). The remaining mice per group were used for overall survival analysis ( b ). Graph represents the Kaplan–Meier survival curves (Log-rank test). c , d NSG mice ( n = 39) were engrafted with MOLM14 cells and daily treated with vehicle or IACS-010759 by gavage. Seventeen days post graft, nine mice vehicle group and 11 mice IACS-010759-treated group were killed, and the number of human cells (hCD45+ and hCD33+) in the bone marrow and spleen was analyzed by flow cytometry. Graphs represent the number of human positive cells for hCD45 and hCD33 within the murine bone marrow and spleen ( c ) (unpaired t -test). The remaining mice were used for overall survival analysis ( d ). Graph represents the Kaplan–Meier survival curves (Log-rank test). e – g Viable bone marrow AML blasts from mice treated with IACS-010759 were stained for Bodipy 493/503 and DAPI. Scale bar: 10 µm ( e ). Histograms show the number or the area of Bodipy 493/503 dots per cell ( f , g ) (unpaired t -test). h Viable bone marrow AML blasts from mice treated with IACS-010759 (one experiment) were subjected to Western blot analysis for actin and LC3B. Numbers indicate ratios obtained by densitometric analysis. i Purified viable bone marrow AML blasts from mice treated with IACS-010759 (one experiment) were subjected to PLA assay. Numbers represent the number of PLA dots per cell (minimum 130 cells, unpaired t -test). Scale bar: 10 µm ( j ). Schematic diagram depicting the interplay between the autophagy process and the mitochondria in AML cells. Autophagy appears as a major regulator of mitochondria activity with the mitochondria controlling its supply of FFAs by regulating the number of autophagosomes via the formation MERCs. Data are means ± s.e.m.

Journal: Nature Communications

Article Title: Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites

doi: 10.1038/s41467-020-17882-2

Figure Lengend Snippet: a , b NSG mice ( n = 31) were engrafted with MOLM14 cells expressing the Ctrl or VDAC1 shRNAs by intravenous injection. Seventeen days post graft, five mice shCtrl and six mice shVDAC1 were killed, and the number of human cells (hCD45+ and hCD33+) in the bone marrow and spleen was analyzed by flow cytometry. Graphs represent the number of human positive cells for hCD45 and hCD33 within the murine bone marrow and spleen from one experiment ( a ) (unpaired t -test). The remaining mice per group were used for overall survival analysis ( b ). Graph represents the Kaplan–Meier survival curves (Log-rank test). c , d NSG mice ( n = 39) were engrafted with MOLM14 cells and daily treated with vehicle or IACS-010759 by gavage. Seventeen days post graft, nine mice vehicle group and 11 mice IACS-010759-treated group were killed, and the number of human cells (hCD45+ and hCD33+) in the bone marrow and spleen was analyzed by flow cytometry. Graphs represent the number of human positive cells for hCD45 and hCD33 within the murine bone marrow and spleen ( c ) (unpaired t -test). The remaining mice were used for overall survival analysis ( d ). Graph represents the Kaplan–Meier survival curves (Log-rank test). e – g Viable bone marrow AML blasts from mice treated with IACS-010759 were stained for Bodipy 493/503 and DAPI. Scale bar: 10 µm ( e ). Histograms show the number or the area of Bodipy 493/503 dots per cell ( f , g ) (unpaired t -test). h Viable bone marrow AML blasts from mice treated with IACS-010759 (one experiment) were subjected to Western blot analysis for actin and LC3B. Numbers indicate ratios obtained by densitometric analysis. i Purified viable bone marrow AML blasts from mice treated with IACS-010759 (one experiment) were subjected to PLA assay. Numbers represent the number of PLA dots per cell (minimum 130 cells, unpaired t -test). Scale bar: 10 µm ( j ). Schematic diagram depicting the interplay between the autophagy process and the mitochondria in AML cells. Autophagy appears as a major regulator of mitochondria activity with the mitochondria controlling its supply of FFAs by regulating the number of autophagosomes via the formation MERCs. Data are means ± s.e.m.

Article Snippet: Mouse antibodies from Santa Cruz Biotechnology against IP3R1 (sc-271197) and E2F1 (KH95), from Millipore against actin, rabbit antibody from Abcam against VDAC1 (ab15865), from PROGEN against ADRP (610102), from R&D System against FABP4 (AF3150), from Atlas Antibodies against ACLY (HPA022434), from Novus Biologicals against SREPB1 (NB600-582), from Invitrogen against SREBP2 (PA1-338), and from GeneTex against TOMM20 (GTX133756) were also used.

Techniques: Expressing, Injection, Flow Cytometry, Staining, Western Blot, Purification, Activity Assay

Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 (VDAC1), and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.

Journal: Nature Communications

Article Title: MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis

doi: 10.1038/s41467-020-16887-1

Figure Lengend Snippet: Wild-type (WT) and MLKL −/− HT29 cells were treated with media alone or the necroptotic stimuli, TNF and Smac-mimetic and pan-caspase inhibitor, IDN-6556, (TSI) for the indicated time period and chronological RIPK1, RIPK3, and MLKL phosphorylation ( a ), plasma membrane lysis ( b ), MLKL oligomerization and membrane-association ( c ), and plasma membrane damage with cell death ( d ) were measured. a Whole-cell lysates were fractioned by SDS-PAGE and immunoblotted to determine the extent of RIPK1, RIPK3 and MLKL phosphorylation over time. The displayed immunoblots are representative of n = 2 independent experiments for RIPK1/3 and n = 4 independent experiments for MLKL. b Left-hand y-axis plots the ratio of the pMLKL and MLKL immunoblot signals (relative to the t = 6 h time point value) across n = 4 independent experiments. Mean ± SD. Right-hand y -axis plots the extracellular release of lactate dehydrogenase (LDH) as an index of plasma membrane lysis (relative to detergent-treated cells) across n = 9 independent experiments. Mean ± SEM. All data are included in the Source Data file. c Subcellular fractions of the cytosol (C) and membrane (M) were subjected to Blue Native-PAGE and immunoblotted to assess MLKL phosphorylation, oligomerization and membrane-association. Fractionation was verified by probing for the membrane protein, voltage-dependent anion channel 1 (VDAC1), and the cytosolic protein, glyceraldehyde-3-phosphosphate dehydrogenase (GAPDH). Data are representative of n = 2 independent experiments. d Sequential time-lapse micrographs of Annexin V binding (Annexin V; green) and propidium iodide-uptake (PI; red) as indices of plasma membrane damage and cell death, respectively. Micrographs are representative of n = 4 independent experiments.

Article Snippet: Primary antibodies (and dilution used for immunoblotting) were: rat anti-MLKL (clone 3H1; produced in-house and available from Merck #MABC604; 1:2000), rat anti-MLKL (clone 7G2; produced in-house; 1:2000), rat anti-MLKL (clone 10C2; produced in-house; 1:2000), rabbit anti-phospho-MLKL phospho-S358 (Abcam #ab187091; 1:1000; referred to as MLKL pS358 when used for immunofluorescence), anti-GAPDH (Merck #MAB374; 1:2000), rat anti-human RIPK3 (clone 1H2; produced in-house ; 1:2000), rabbit anti-phospho-RIPK3 phospho-S227 (Abcam #ab 209384; 1:1000), rabbit-anti-RIPK1 (Cell Signaling Technology # 3493; 1:1000) mouse anti-Vti1a (BD Biosciences; Cat#6112200), sheep anti-tubulin (Cytoskeleton, Inc. # ATN02), mouse anti-actin (Abcam #ab14128; used in Fig. ), anti-β-Actin (Sigma #A1987; used in Supplementary Fig. ; 1:2000), anti-VDAC1 (Merck #AB10527; 1:1000), anti-ZO-1 (ThermoFisher Scientific #33-9100; 1:1000), anti-occludin (ThermoFisher Scientific #33-1500; 1:1000), anti-JAM-A (Santa Cruz Biotechnology #sc-53623), anti-TOMM20 (Santa Cruz Biotechnology #sc-17764), anti-LAMP-2 (Santa Cruz Biotechnology #sc-18822), anti-Flotillin (BD Transduction Laboratories #610821), anti-20S (Santa Cruz Biotechnology #sc-374405), anti-HSP90α/β (Santa Cruz Biotechnology #sc-13119), anti-E-cadherin (Santa Cruz Biotechnology #sc-8426), anti-Desmoglein 2 (Santa Cruz Biotechnology #sc-80663).

Techniques: Lysis, SDS Page, Western Blot, Blue Native PAGE, Fractionation, Binding Assay

a Images of TSI-treated HT29 cells expressing Mb37 stained for MLKL 10C2 , MLKL pS358 and DNA (Hoechst). b Mean frequency of clusters and hotspots from n = 2 independent experiments ( N > 1500 cells per group) with raw lactate dehydrogenase (LDH) release values taken from the same samples. c – g Necrosulfonamide (NSA) was added to HT29 cells together with TNF, Smac mimetic and IDN-6556 (TSI) or 4–6 h after TSI addition. Plasma membrane lysis (LDH release; line shows mean of 4 biological replicates indicated as dots; data representative of n = 3 independent experiments) ( d ), MLKL activation ( e ) and hotspots ( f, g ) were measured after 7.5 h of TSI-treatment. e Cytosol (C) and membrane (M) fractions resolved by Blue Native-PAGE and immunoblotted for MLKL and MLKL pS358 . Uncropped blots are included as Source Data. Fractionation was verified by probing for voltage-dependent anion channel 1 (VDAC1; membrane), glyceraldehyde-3-phosphosphate dehydrogenase GAPDH (cytosol); representative of n = 2 independent experiments. f Mean frequency, intensity and size of hotspots from one experiment ( N = 1309-1740 cells per group); representative of n = 3 independent experiments.

Journal: Nature Communications

Article Title: MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis

doi: 10.1038/s41467-020-16887-1

Figure Lengend Snippet: a Images of TSI-treated HT29 cells expressing Mb37 stained for MLKL 10C2 , MLKL pS358 and DNA (Hoechst). b Mean frequency of clusters and hotspots from n = 2 independent experiments ( N > 1500 cells per group) with raw lactate dehydrogenase (LDH) release values taken from the same samples. c – g Necrosulfonamide (NSA) was added to HT29 cells together with TNF, Smac mimetic and IDN-6556 (TSI) or 4–6 h after TSI addition. Plasma membrane lysis (LDH release; line shows mean of 4 biological replicates indicated as dots; data representative of n = 3 independent experiments) ( d ), MLKL activation ( e ) and hotspots ( f, g ) were measured after 7.5 h of TSI-treatment. e Cytosol (C) and membrane (M) fractions resolved by Blue Native-PAGE and immunoblotted for MLKL and MLKL pS358 . Uncropped blots are included as Source Data. Fractionation was verified by probing for voltage-dependent anion channel 1 (VDAC1; membrane), glyceraldehyde-3-phosphosphate dehydrogenase GAPDH (cytosol); representative of n = 2 independent experiments. f Mean frequency, intensity and size of hotspots from one experiment ( N = 1309-1740 cells per group); representative of n = 3 independent experiments.

Article Snippet: Primary antibodies (and dilution used for immunoblotting) were: rat anti-MLKL (clone 3H1; produced in-house and available from Merck #MABC604; 1:2000), rat anti-MLKL (clone 7G2; produced in-house; 1:2000), rat anti-MLKL (clone 10C2; produced in-house; 1:2000), rabbit anti-phospho-MLKL phospho-S358 (Abcam #ab187091; 1:1000; referred to as MLKL pS358 when used for immunofluorescence), anti-GAPDH (Merck #MAB374; 1:2000), rat anti-human RIPK3 (clone 1H2; produced in-house ; 1:2000), rabbit anti-phospho-RIPK3 phospho-S227 (Abcam #ab 209384; 1:1000), rabbit-anti-RIPK1 (Cell Signaling Technology # 3493; 1:1000) mouse anti-Vti1a (BD Biosciences; Cat#6112200), sheep anti-tubulin (Cytoskeleton, Inc. # ATN02), mouse anti-actin (Abcam #ab14128; used in Fig. ), anti-β-Actin (Sigma #A1987; used in Supplementary Fig. ; 1:2000), anti-VDAC1 (Merck #AB10527; 1:1000), anti-ZO-1 (ThermoFisher Scientific #33-9100; 1:1000), anti-occludin (ThermoFisher Scientific #33-1500; 1:1000), anti-JAM-A (Santa Cruz Biotechnology #sc-53623), anti-TOMM20 (Santa Cruz Biotechnology #sc-17764), anti-LAMP-2 (Santa Cruz Biotechnology #sc-18822), anti-Flotillin (BD Transduction Laboratories #610821), anti-20S (Santa Cruz Biotechnology #sc-374405), anti-HSP90α/β (Santa Cruz Biotechnology #sc-13119), anti-E-cadherin (Santa Cruz Biotechnology #sc-8426), anti-Desmoglein 2 (Santa Cruz Biotechnology #sc-80663).

Techniques: Expressing, Staining, Lysis, Activation Assay, Blue Native PAGE, Fractionation

( A ) SDS-PAGE and Western blot analysis of cytosolic and mitochondrial fractions isolated from PHSFs from control subjects (CT1, CT2) and the three patients (P1-EMRE, P2-EMRE, P3-MICU1). Antibodies against EMRE, MICU1, MCU, VDAC1 (mitochondrial marker) and β-actin (cytosolic marker) were used. Two EMRE-positive bands were detected in CT1 and CT2 cells (green boxes), whereas such bands were not detected in P1-EMRE, P2-EMRE and P3-MICU1 cells (red boxes). The saturated (red) pixels on the left of the blot are derived from the MW markers (also see Supplementary figure 2 ). Numerals indicate molecular weight in kDa. ( B ) Native gel (BN-PAGE) and Western blot analysis of mitochondria-enriched fractions isolated from PHSFs and stained with antibodies against MCU and OXPHOS complex II (CII; loading control). The fully assembled MCU complex (“MCU complex”) and the subcomplex lacking the EMRE or MICU1 subunit (“MCU subcomplex”) are indicated.

Journal: bioRxiv

Article Title: SMDT1 variants impair EMRE-mediated mitochondrial calcium uptake in patients with muscle involvement

doi: 10.1101/2022.10.31.514480

Figure Lengend Snippet: ( A ) SDS-PAGE and Western blot analysis of cytosolic and mitochondrial fractions isolated from PHSFs from control subjects (CT1, CT2) and the three patients (P1-EMRE, P2-EMRE, P3-MICU1). Antibodies against EMRE, MICU1, MCU, VDAC1 (mitochondrial marker) and β-actin (cytosolic marker) were used. Two EMRE-positive bands were detected in CT1 and CT2 cells (green boxes), whereas such bands were not detected in P1-EMRE, P2-EMRE and P3-MICU1 cells (red boxes). The saturated (red) pixels on the left of the blot are derived from the MW markers (also see Supplementary figure 2 ). Numerals indicate molecular weight in kDa. ( B ) Native gel (BN-PAGE) and Western blot analysis of mitochondria-enriched fractions isolated from PHSFs and stained with antibodies against MCU and OXPHOS complex II (CII; loading control). The fully assembled MCU complex (“MCU complex”) and the subcomplex lacking the EMRE or MICU1 subunit (“MCU subcomplex”) are indicated.

Article Snippet: Subsequently, the blots were incubated with one of the following primary antibodies in Intercept Blocking Buffer supplemented with 0.1% (v/v) Tween-20 overnight at 4°C: an WB-optimized EMRE antibody (anti-EMRE; #A300-BL19208, 1:250; Bethyl Laboratories, Montgomery, TX, USA ), anti-MICU1/CALC/CBARA1 (#LN2014887, 1:2000; Labned, Amstelveen, The Netherlands ), anti-MCU/C1orf42/CCDC109A (#26312-1-AP, 1:2000; Proteintech, Rosemont, IL, USA ), anti-VDAC1/Porin (#MABN504, 1:1000; Merck ), anti-β-Actin/ACTB (#A5441, 1:100,000; Merck ), anti-V5 (#R960-25; 1:5000; Thermo Fischer ).

Techniques: SDS Page, Western Blot, Isolation, Marker, Derivative Assay, Molecular Weight, Staining